Efficacy and safety of mesenchymal stromal cells for the prophylaxis of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of mesenchymal stromal cells for the prophylaxis of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a meta-analysis of randomized controlled trials

Published:2018-06-08 Issue:10 Volume:97 Page:1941-1950
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Wang Li,Zhu Cheng-ying,Ma De-xun,Gu Zhen-yang,Xu Chang-chun,Wang Fei-yan,Chen Ji-gang,Liu Cheng-jun,Guan Li-xun,Gao Rui,Gao Zhe,Fang Shu,Zhuo Du-jun,Liu Shu-feng,Gao Chun-ji

Funder

National Natural Science Foundation of China

Beijing Municipal Natural Science Foundation

Hainan Social Development Special Funding

Four Hundreds Program of Chinese PLA General Hospital

Military Logistics Program

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/article/10.1007/s00277-018-3384-8/fulltext.html

Reference59 articles.

1. Copelan EA (2006) Hematopoietic stem-cell transplantation. N Engl J Med 354(17):1813–1826. https://doi.org/10.1056/NEJMra052638

2. Socié G, Ritz J (2014) Current issues in chronic graft-versus-host disease. Blood 124(3):374–384. https://doi.org/10.1182/blood-2014-01-514752

3. Kurosawa S, Oshima K, Yamaguchi T, Yanagisawa A, Fukuda T, Kanamori H, Mori T, Takahashi S, Kondo T, Kohno A, Miyamura K, Umemoto Y, Teshima T, Taniguchi S, Yamashita T, Inamoto Y, Kanda Y, Okamoto S, Atsuta Y (2017) Quality of life after allogeneic hematopoietic cell transplantation according to affected organ and severity of chronic graft-versus-host disease. Biol Blood Marrow Transplant 23(10):1749–1758. https://doi.org/10.1016/j.bbmt.2017.06.011

4. Sun CL, Kersey JH, Francisco L, Armenian SH, Baker KS, Weisdorf DJ, Forman SJ, Bhatia S (2013) Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study. Biol Blood Marrow Transplant 19(7):1073–1080. https://doi.org/10.1016/j.bbmt.2013.04.002

5. Krampera M, Glennie S, Dyson J, Scott D, Laylor R, Simpson E, Dazzi F (2003) Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101(9):3722–3729. https://doi.org/10.1182/blood-2002-07-2104

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microcarrier-based clinical-grade manufacturing of therapeutic Wharton's jelly mesenchymal stromal cells;Cytotherapy;2024-07

2. Graft-Versus-Host Disease;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

3. Update on the Use of Mesenchymal Stem Cells and their Products in Hematopoietic Stem Cell Transplantation;Journal of Stem Cell Therapy and Transplantation;2023-11-29

4. Synergistic Effect of Human Chorionic Gonadotropin and Granulocyte Colony Stimulating Factor in the Mobilization of HSPCs Improves Overall Survival After PBSCT in a Preclinical Murine Model. Are We Far Enough for Therapy?;Stem Cell Reviews and Reports;2023-11-03

5. Optimal Intravenous Administration Procedure for Efficient Delivery of Canine Adipose-Derived Mesenchymal Stem Cells;International Journal of Molecular Sciences;2022-11-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3